Position in GRTXD
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$4
New position
Shares Held
93
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 1 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ascentis Independent Advisors holds $30,103 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
100 | $30,103 |
All Filings in GRTXD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4 | 93 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||